Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

516 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Analysis of long-term survivors with cardiac AL amyloidosis].
Kagawa K, Maeda Y, Oura M, Sogabe K, Fujino H, Takahashi M, Maruhashi T, Iwasa M, Udaka K, Harada T, Ise T, Fujii S, Nakamura S, Miki H, Yagi S, Takeuchi K, Ozaki S, Abe M. Kagawa K, et al. Among authors: iwasa m. Rinsho Ketsueki. 2017;58(11):2197-2204. doi: 10.11406/rinketsu.58.2197. Rinsho Ketsueki. 2017. PMID: 29212969 Japanese.
Expansion of Th1-like Vγ9Vδ2T cells by new-generation IMiDs, lenalidomide and pomalidomide, in combination with zoledronic acid.
Harada T, Miki H, Cui Q, Oda A, Amachi R, Teramachi J, Bat-Erdene A, Sogabe K, Iwasa M, Fujii S, Nakamura S, Kagawa K, Yoshida S, Endo I, Aihara K, Ozaki S, Matsumoto T, Abe M. Harada T, et al. Among authors: iwasa m. Leukemia. 2017 Jan;31(1):258-262. doi: 10.1038/leu.2016.273. Epub 2016 Oct 4. Leukemia. 2017. PMID: 27698446 No abstract available.
Combination with a defucosylated anti-HM1.24 monoclonal antibody plus lenalidomide induces marked ADCC against myeloma cells and their progenitors.
Harada T, Ozaki S, Oda A, Tsuji D, Ikegame A, Iwasa M, Udaka K, Fujii S, Nakamura S, Miki H, Kagawa K, Kuroda Y, Kawai S, Itoh K, Yamada-Okabe H, Matsumoto T, Abe M. Harada T, et al. Among authors: iwasa m. PLoS One. 2013 Dec 26;8(12):e83905. doi: 10.1371/journal.pone.0083905. eCollection 2013. PLoS One. 2013. PMID: 24386306 Free PMC article.
A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alteration.
Amachi R, Hiasa M, Teramachi J, Harada T, Oda A, Nakamura S, Hanson D, Watanabe K, Fujii S, Miki H, Kagawa K, Iwasa M, Endo I, Kondo T, Yoshida S, Aihara KI, Kurahashi K, Kuroda Y, Horikawa H, Tanaka E, Matsumoto T, Abe M. Amachi R, et al. Among authors: iwasa m. Oncotarget. 2016 Oct 25;7(43):70447-70461. doi: 10.18632/oncotarget.11927. Oncotarget. 2016. PMID: 27626482 Free PMC article.
Pim-2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma.
Teramachi J, Hiasa M, Oda A, Harada T, Nakamura S, Amachi R, Tenshin H, Iwasa M, Fujii S, Kagawa K, Miki H, Kurahashi K, Yoshida S, Endo I, Haneji T, Matsumoto T, Abe M. Teramachi J, et al. Among authors: iwasa m. Br J Haematol. 2018 Feb;180(4):581-585. doi: 10.1111/bjh.14388. Epub 2016 Oct 17. Br J Haematol. 2018. PMID: 27748523 Free article. No abstract available.
Correlation between high serum alkaline phosphatase levels and denosumab-related hypocalcemia in patients with multiple myeloma.
Miki H, Nakamura S, Oura M, Hamano H, Ikuta K, Okada N, Okamoto Y, Sogabe K, Takahashi M, Iwasa M, Udaka K, Harada T, Kurahashi K, Fujii S, Yoshida S, Kagawa K, Endo I, Aihara KI, Abe M. Miki H, et al. Among authors: iwasa m. Br J Haematol. 2019 Jul;186(2):355-358. doi: 10.1111/bjh.15837. Epub 2019 Mar 11. Br J Haematol. 2019. PMID: 30859556 Free article. Clinical Trial. No abstract available.
516 results